Heterocyclic derivatives as histamine h-2 receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260/259, 260/300

C07D 239/28 (2006.01) C07D 213/73 (2006.01) C07D 213/75 (2006.01) C07D 231/16 (2006.01) C07D 231/40 (2006.01) C07D 239/42 (2006.01) C07D 239/46 (2006.01) C07D 239/545 (2006.01) C07D 249/04 (2006.01) C07D 249/08 (2006.01) C07D 249/14 (2006.01) C07D 257/06 (2006.01) C07D 403/02 (2006.01)

Patent

CA 1200549

ABSTRACT HETEROCYCLIC DERIVATIVES This invention relates to heterocyclic derivatives which are histamine H-2 antagonists and which inhibit gastric acid secretion. According to the invention there is provided a guanidine derivative of the formula I:- Image in which R1 and R2, same or different, are hydrogen or 1-10C alkyl, 3-8C cycloalkyl, 4-14C cycloalkylalkyl, each alkyl, cycloalkyl or cycloalkylalkyl optionally carrying one or more F, Cl or Br atoms, provided that one of R1 and R2 is halogen-substituted, or R2 is hydrogen and R1 is R5-E-W- in which W is 2-6 alkylene optionally substituted by 1or2 1-4C alkyls, E is O,S,SO,SO2 or NR6 in which R6 is H or 1-6C alkyl, R5 is H or 1-6C alkyl optionally substituted by 1 or 2 1-4C alkyls, or R5 and R6 are joined to form a pyrrolidine, piperidine, morpholine, piperazine or N-methylpiperazine ring; ring Xis a heterocyclic ring as defined in the specification; A is phenylene or 5-7C cycloalkylene, or a 1-8C alkylene into which is optionally inserted one or two groups; and R3 and R4 are a variety of radicals described in the specification: and the pharmaceutically-acceptable acid-addition salts thereof. Manufacturing processes and pharmaceutical compositions are also described.

398640

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic derivatives as histamine h-2 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic derivatives as histamine h-2 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic derivatives as histamine h-2 receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1208340

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.